Redcliffe Partners advised CVC on obtaining merger clearance from the Ukrainian competition authority for its acquisition of Recordati S.p.A. (Recordati). The deal is valued at approximately EUR 3 billion. Through its expertise and global healthcare network CVC will expand Recordati’s rare disease business and accelerate its growth strategy as a leading global company in the pharmaceutical industry. Redcliffe’s team working…
Read MoreRedcliffe Partners advised Stahl Lux 2 S.A. on obtaining merger clearance from the Antimonopoly Committee of Ukraine for the acquisition of the leather chemicals business of BASF SE. As part of the transaction, BASF will receive a 16% minority stake in the Stahl Group, and Stahl will take over BASF’s global leather chemicals business – with approximately 210 employees globally…
Read More